BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

663 related articles for article (PubMed ID: 27442039)

  • 1. Quantitative diffusion-weighted imaging and dynamic contrast-enhanced characterization of the index lesion with multiparametric MRI in prostate cancer patients.
    Yuan Q; Costa DN; Sénégas J; Xi Y; Wiethoff AJ; Rofsky NM; Roehrborn C; Lenkinski RE; Pedrosa I
    J Magn Reson Imaging; 2017 Mar; 45(3):908-916. PubMed ID: 27442039
    [TBL] [Abstract][Full Text] [Related]  

  • 2. DCE-MRI of the prostate using shutter-speed vs. Tofts model for tumor characterization and assessment of aggressiveness.
    Hectors SJ; Besa C; Wagner M; Jajamovich GH; Haines GK; Lewis S; Tewari A; Rastinehad A; Huang W; Taouli B
    J Magn Reson Imaging; 2017 Sep; 46(3):837-849. PubMed ID: 28092414
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Optimized Fast Dynamic Contrast-Enhanced Magnetic Resonance Imaging of the Prostate: Effect of Sampling Duration on Pharmacokinetic Parameters.
    Othman AE; Falkner F; Martirosian P; Schraml C; Schwentner C; Nickel D; Nikolaou K; Notohamiprodjo M
    Invest Radiol; 2016 Feb; 51(2):106-12. PubMed ID: 26447494
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Evaluation of Diffusion Kurtosis Imaging Versus Standard Diffusion Imaging for Detection and Grading of Peripheral Zone Prostate Cancer.
    Roethke MC; Kuder TA; Kuru TH; Fenchel M; Hadaschik BA; Laun FB; Schlemmer HP; Stieltjes B
    Invest Radiol; 2015 Aug; 50(8):483-9. PubMed ID: 25867657
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Peripheral zone prostate cancer localization by multiparametric magnetic resonance at 3 T: unbiased cancer identification by matching to histopathology.
    Selnæs KM; Heerschap A; Jensen LR; Tessem MB; Schweder GJ; Goa PE; Viset T; Angelsen A; Gribbestad IS
    Invest Radiol; 2012 Nov; 47(11):624-33. PubMed ID: 23011187
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Intravoxel incoherent motion diffusion-weighted imaging of hepatocellular carcinoma: Is there a correlation with flow and perfusion metrics obtained with dynamic contrast-enhanced MRI?
    Hectors SJ; Wagner M; Besa C; Bane O; Dyvorne HA; Fiel MI; Zhu H; Donovan M; Taouli B
    J Magn Reson Imaging; 2016 Oct; 44(4):856-64. PubMed ID: 26919327
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Improved diagnostic accuracy with multiparametric magnetic resonance imaging of the breast using dynamic contrast-enhanced magnetic resonance imaging, diffusion-weighted imaging, and 3-dimensional proton magnetic resonance spectroscopic imaging.
    Pinker K; Bogner W; Baltzer P; Gruber S; Bickel H; Brueck B; Trattnig S; Weber M; Dubsky P; Bago-Horvath Z; Bartsch R; Helbich TH
    Invest Radiol; 2014 Jun; 49(6):421-30. PubMed ID: 24566292
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Optimal high b-value for diffusion weighted MRI in diagnosing high risk prostate cancers in the peripheral zone.
    Agarwal HK; Mertan FV; Sankineni S; Bernardo M; Senegas J; Keupp J; Daar D; Merino M; Wood BJ; Pinto PA; Choyke PL; Turkbey B
    J Magn Reson Imaging; 2017 Jan; 45(1):125-131. PubMed ID: 27383502
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Novel PCA-VIP scheme for ranking MRI protocols and identifying computer-extracted MRI measurements associated with central gland and peripheral zone prostate tumors.
    Ginsburg SB; Viswanath SE; Bloch BN; Rofsky NM; Genega EM; Lenkinski RE; Madabhushi A
    J Magn Reson Imaging; 2015 May; 41(5):1383-93. PubMed ID: 24943647
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Correlation of quantitative diffusion-weighted and dynamic contrast-enhanced MRI parameters with prognostic factors in prostate cancer.
    Chung MP; Margolis D; Mesko S; Wang J; Kupelian P; Kamrava M
    J Med Imaging Radiat Oncol; 2014 Oct; 58(5):588-94. PubMed ID: 25196228
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Diffusion-Weighted Imaging With Apparent Diffusion Coefficient Mapping for Breast Cancer Detection as a Stand-Alone Parameter: Comparison With Dynamic Contrast-Enhanced and Multiparametric Magnetic Resonance Imaging.
    Pinker K; Moy L; Sutton EJ; Mann RM; Weber M; Thakur SB; Jochelson MS; Bago-Horvath Z; Morris EA; Baltzer PA; Helbich TH
    Invest Radiol; 2018 Oct; 53(10):587-595. PubMed ID: 29620604
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Evaluation of extracapsular extension in prostate cancer using qualitative and quantitative multiparametric MRI.
    Kim W; Kim CK; Park JJ; Kim M; Kim JH
    J Magn Reson Imaging; 2017 Jun; 45(6):1760-1770. PubMed ID: 27749009
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Differentiation of central gland prostate cancer from benign prostatic hyperplasia using monoexponential and biexponential diffusion-weighted imaging.
    Liu X; Zhou L; Peng W; Wang C; Wang H
    Magn Reson Imaging; 2013 Oct; 31(8):1318-24. PubMed ID: 23791546
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparing diagnostic accuracy of luminal water imaging with diffusion-weighted and dynamic contrast-enhanced MRI in prostate cancer: A quantitative MRI study.
    Sabouri S; Chang SD; Goldenberg SL; Savdie R; Jones EC; Black PC; Fazli L; Kozlowski P
    NMR Biomed; 2019 Feb; 32(2):e4048. PubMed ID: 30575145
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of Temporal Resolution on Diagnostic Performance of Dynamic Contrast-Enhanced Magnetic Resonance Imaging of the Prostate.
    Othman AE; Falkner F; Weiss J; Kruck S; Grimm R; Martirosian P; Nikolaou K; Notohamiprodjo M
    Invest Radiol; 2016 May; 51(5):290-6. PubMed ID: 26619282
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Patient-specific pharmacokinetic parameter estimation on dynamic contrast-enhanced MRI of prostate: Preliminary evaluation of a novel AIF-free estimation method.
    Ginsburg SB; Taimen P; Merisaari H; Vainio P; Boström PJ; Aronen HJ; Jambor I; Madabhushi A
    J Magn Reson Imaging; 2016 Dec; 44(6):1405-1414. PubMed ID: 27285161
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Intravoxel incoherent motion (IVIM) in evaluation of breast lesions: comparison with conventional DWI.
    Liu C; Liang C; Liu Z; Zhang S; Huang B
    Eur J Radiol; 2013 Dec; 82(12):e782-9. PubMed ID: 24034833
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Assessment of renal function using intravoxel incoherent motion diffusion-weighted imaging and dynamic contrast-enhanced MRI.
    Bane O; Wagner M; Zhang JL; Dyvorne HA; Orton M; Rusinek H; Taouli B
    J Magn Reson Imaging; 2016 Aug; 44(2):317-26. PubMed ID: 26855407
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Diffusion-weighted imaging in the assessment of prostate cancer: Comparison of zoomed imaging and conventional technique.
    Brendle C; Martirosian P; Schwenzer NF; Kaufmann S; Kruck S; Kramer U; Notohamiprodjo M; Nikolaou K; Schraml C
    Eur J Radiol; 2016 May; 85(5):893-900. PubMed ID: 27130048
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Intravoxel incoherent motion diffusion-weighted imaging as an adjunct to dynamic contrast-enhanced MRI to improve accuracy of the differential diagnosis of benign and malignant breast lesions.
    Ma D; Lu F; Zou X; Zhang H; Li Y; Zhang L; Chen L; Qin D; Wang B
    Magn Reson Imaging; 2017 Feb; 36():175-179. PubMed ID: 27742437
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 34.